![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on KEYNOTE-651: Pembrolizumab + mFOLFOX7/FOLFIRI for mCRC: Long-Term Follow-Up of Cohorts B and D
By
ASCO 2022 Conference Coverage
FEATURING
Richard Kim
By
ASCO 2022 Conference Coverage
FEATURING
Richard Kim
2,337 views
June 9, 2022
Login to view comments.
Click here to Login
GI